New Delhi, Apr 8 () Indian Immunologicals, a subsidiary of National Dairy Development Board (NDDB), has inked agreement with Australia's Griffith University to develop a vaccine for coronavirus.
Hyderabad-based Indian Immunologicals Ltd (IIL) is already working with Griffith University for conducting research and development of Zika virus vaccine, which is currently at pre-clinical toxicology testing stage, the NDDB said in a statement.
Announcing the collaboration, Dilip Rath, Chairman of NDDB and IIL, said: "In this significant cross-continental collaboration, scientists from IIL and Griffith University will jointly develop a 'Live Attenuated SARS – CoV-2 vaccine' or Covid-19 vaccine using the latest codon de-optimisation technology".
This technology looks promising for developing a vaccine for prophylactic, active, single dose immunization against coronavirus in humans, with an enhanced safety profile, Rath said.
"The vaccine is expected to provide long-lasting protection," he said.
Upon completion of the research, the vaccine strain will be transferred to IIL and the vaccine maker will work accordingly with the country's regulator – Central Drugs Standard Control Organisation (CDSCO) - to further conduct clinical trials in a phased manner.
Professor Suresh Mahalingam, Menzies Health Institute Queensland, Griffith University, Australia said, "We are very excited to be able to work closely with IIL for development of this important vaccine".
"As this vaccine will be a live attenuated vaccine, it is expected to be highly effective by providing very strong cellular and antibody immune responses against the virus," he said.
The other benefit of a live-attenuated vaccine is a proven track record for economical large-scale manufacturing and well-known regulatory approval pathway, Mahalingam said.
Rath said the IIL is a prominent player in veterinary biologicals and committed to addressing critical public health needs.
IIL is one of the largest producers of Foot and Mouth disease vaccine in the world and was the first company in India to launch the purified Vero cell rabies vaccine for humans (PVRV), the statement said.
The death toll due to the novel coronavirus rose to 149 and the number of cases climbed to 5, 274 in the country on Wednesday, registering an increase of 485 cases in the last 24 hours, according to the Union Health Ministry. MJH BALBAL
Next Story
I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
India's forex reserves sufficient to cover 11 months of projected imports
ITC plans to open more hotels overseas: CMD Sanjiv Puri
2024 LS polls pegged as costliest ever, expenditure may touch ₹1.35 lakh crore: Expert
10 Best things to do in India for tourists
19,000 school job losers likely to be eligible recruits: Bengal SSC
